BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21672525)

  • 1. MiR-192 inhibits nucleotide excision repair by targeting ERCC3 and ERCC4 in HepG2.2.15 cells.
    Xie QH; He XX; Chang Y; Sun SZ; Jiang X; Li PY; Lin JS
    Biochem Biophys Res Commun; 2011 Jul; 410(3):440-5. PubMed ID: 21672525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210.
    Zhang GL; Li YX; Zheng SQ; Liu M; Li X; Tang H
    Antiviral Res; 2010 Nov; 88(2):169-75. PubMed ID: 20728471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatitis B virus-associated estrogen receptor alpha (ERalpha) was regulated by microRNA-130a in HepG2.2.15 human hepatocellular carcinoma cells.
    Tang L; Pu Y; Wong DK; Liu T; Tang H; Xiang T; Yuen MF; Ren G
    Acta Biochim Biophys Sin (Shanghai); 2011 Aug; 43(8):640-6. PubMed ID: 21712254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of glutathione in the regulation of nucleotide excision repair during oxidative stress.
    Langie SA; Knaapen AM; Houben JM; van Kempen FC; de Hoon JP; Gottschalk RW; Godschalk RW; van Schooten FJ
    Toxicol Lett; 2007 Feb; 168(3):302-9. PubMed ID: 17207589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells.
    Xie X; Huang N; Zhang Y; Wei X; Gao M; Li M; Ning J; Liu W; Zhao Q; Wang H; Gu K
    J Cancer; 2019; 10(4):1039-1051. PubMed ID: 30854110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition.
    de Boer J; van Steeg H; Berg RJ; Garssen J; de Wit J; van Oostrum CT; Beems RB; van der Horst GT; van Kreijl CF; de Gruijl FR; Bootsma D; Hoeijmakers JH; Weeda G
    Cancer Res; 1999 Jul; 59(14):3489-94. PubMed ID: 10416615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleotide excision repair is not required for the antiapoptotic function of insulin-like growth factor 1.
    Lee-Kwon W; Park D; Bernier M
    Exp Cell Res; 1998 Jun; 241(2):458-66. PubMed ID: 9637787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excision repair cross complementing 3 expression is involved in patient prognosis and tumor progression in esophageal cancer.
    Terashita Y; Ishiguro H; Haruki N; Sugiura H; Tanaka T; Kimura M; Shinoda N; Kuwabara Y; Fujii Y
    Oncol Rep; 2004 Oct; 12(4):827-31. PubMed ID: 15375507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
    Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G
    Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and identification of a human liver specific microRNA eukaryotic expression vector.
    Chen S; Ni M; Yu B; Lv T; Lu M; Gong F
    Cell Mol Immunol; 2007 Dec; 4(6):473-7. PubMed ID: 18163960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-125b inhibits hepatitis B virus expression in vitro through targeting of the SCNN1A gene.
    Zhang Z; Chen J; He Y; Zhan X; Zhao R; Huang Y; Xu H; Zhu Z; Liu Q
    Arch Virol; 2014 Dec; 159(12):3335-43. PubMed ID: 25173609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection.
    Qi P; Dou TH; Geng L; Zhou FG; Gu X; Wang H; Gao CF
    Hum Immunol; 2010 Jun; 71(6):621-6. PubMed ID: 20188135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.
    Patel JB; Appaiah HN; Burnett RM; Bhat-Nakshatri P; Wang G; Mehta R; Badve S; Thomson MJ; Hammond S; Steeg P; Liu Y; Nakshatri H
    Oncogene; 2011 Mar; 30(11):1290-301. PubMed ID: 21057539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-155 targets the SKI gene in human melanoma cell lines.
    Levati L; Pagani E; Romani S; Castiglia D; Piccinni E; Covaciu C; Caporaso P; Bondanza S; Antonetti FR; Bonmassar E; Martelli F; Alvino E; D'Atri S
    Pigment Cell Melanoma Res; 2011 Jun; 24(3):538-50. PubMed ID: 21466664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of aryl hydrocarbon- (Ah) receptor and genotoxins on DNA repair gene expression and cell survival of mouse hepatoma cells.
    Schreck I; Chudziak D; Schneider S; Seidel A; Platt KL; Oesch F; Weiss C
    Toxicology; 2009 May; 259(3):91-6. PubMed ID: 19428948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoring DNA repair capacity of cells from three distinct diseases by XPD gene-recombinant adenovirus.
    Armelini MG; Muotri AR; Marchetto MC; de Lima-Bessa KM; Sarasin A; Menck CF
    Cancer Gene Ther; 2005 Apr; 12(4):389-96. PubMed ID: 15650764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-200c reverses drug resistance of human gastric cancer cells by targeting regulation of the NER-ERCC3/4 pathway.
    Li M; Gao M; Xie X; Zhang Y; Ning J; Liu P; Gu K
    Oncol Lett; 2019 Jul; 18(1):145-152. PubMed ID: 31289483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target identification of microRNAs expressed highly in human embryonic stem cells.
    Li SS; Yu SL; Kao LP; Tsai ZY; Singh S; Chen BZ; Ho BC; Liu YH; Yang PC
    J Cell Biochem; 2009 Apr; 106(6):1020-30. PubMed ID: 19229866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered virus-encoded pre-microRNA (pre-miRNA) induces sequence-specific antiviral response in addition to nonspecific immunity in a fish cell line: convergence of RNAi-related pathways and IFN-related pathways in antiviral response.
    Dang LT; Kondo H; Aoki T; Hirono I
    Antiviral Res; 2008 Dec; 80(3):316-23. PubMed ID: 18687362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7.
    Sun Y; Bai Y; Zhang F; Wang Y; Guo Y; Guo L
    Biochem Biophys Res Commun; 2010 Jan; 391(3):1483-9. PubMed ID: 20034472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.